Friday, April 24, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Consumer & Luxury

Altria Executives Report Share Transactions Under Pre-Arranged Plans

SiterGedge by SiterGedge
March 10, 2026
in Consumer & Luxury, Insider Trading
0
Altria Stock
0
SHARES
16
VIEWS
Share on FacebookShare on Twitter

Two senior executives at tobacco giant Altria Group Inc. have recently reported changes to their equity holdings, with both transactions characterized as routine. The moves were executed under predetermined trading plans, a mechanism designed to prevent insider trading by scheduling transactions in advance, thereby negating any suggestion they were based on material non-public information.

Details of the Executive Trades

The first transaction involved Charles N. Whitaker, who serves as the company’s Chief Human Resources Officer and Chief Compliance Officer. On March 5, 2026, Whitaker sold a total of 27,908 shares at an average price of $67.57 per share. This sale generated proceeds of approximately $1.89 million. Following this divestment, his direct holdings stand at 180,869 shares. This total includes 60,552 restricted stock units. Additionally, he holds an indirect interest in 1,017 more shares through the company’s Deferred Profit-Sharing Plan.

In a separate filing from early March, Robert A. McCarter III, Altria’s Executive Vice President and General Counsel, reported a change in his position. He received 5,767 shares following the vesting of performance stock units. Concurrently, and as is standard practice, he surrendered 4,517 of those shares to cover associated tax liabilities—a non-discretionary, automated procedure. After these adjustments, McCarter’s direct share ownership totals 123,612 shares.

Should investors sell immediately? Or is it worth buying Altria?

Strategic Focus and Financial Guidance Remain Unchanged

These insider transactions occur as the company continues to execute its long-term operational strategy. During the Consumer Analyst Group of New York Conference in February 2026, management reaffirmed its full-year outlook. For the 2026 fiscal year, Altria anticipates adjusted diluted earnings per share (EPS) to land in the range of $5.56 to $5.72, with the pace of growth expected to accelerate in the latter half of the year. This forecast follows a reported fourth-quarter 2025 EPS of $1.30.

The company continues to pay a regular quarterly dividend of $1.06 per share. Strategically, Altria is focused on gradually building a portfolio of smoke-free products, an initiative funded by the cash flows from its core traditional tobacco business.

Ad

Altria Stock: Buy or Sell?! New Altria Analysis from April 24 delivers the answer:

The latest Altria figures speak for themselves: Urgent action needed for Altria investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 24.

Altria: Buy or sell? Read more here...

Tags: Altria
SiterGedge

SiterGedge

Related Posts

TUI Stock
Consumer & Luxury

TUI’s Twin Headwinds: A Profit Warning Meets a Fleet Reroute

April 24, 2026
Take-Two Stock
Analysis

Take-Two Interactive: Institutional Heavyweights Pile In Ahead of Earnings

April 23, 2026
PayPal Stock
Analysis

PayPal’s Contrarian Magnet Pulls in Michael Burry as Wall Street Wavers

April 23, 2026
Next Post
Boeing Stock

Boeing Shares Surge on Prospect of Major China Order

Johnson & Johnson Stock

Johnson & Johnson's Oncology Pipeline Gains Momentum with Dual Drug Approvals

Applied Digital Stock

Applied Digital Secures Major Funding for AI Infrastructure Push

Recommended

QuantumScape Stock

Insider Selling Raises Questions About QuantumScape’s Future

5 months ago

Analyst Downgrades WestRock Stock with Revised Price Target

2 years ago
Goldpreis LBMA Stock

Gold Retreats as Surging Oil Prices Trigger Market Liquidation

1 month ago
Block (ex Square) Stock

Block Faces Legal Challenge Amid Bitcoin Payment Expansion

7 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Newmont Mining Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

BioNTech’s ADC Breakthrough Fuels Rally as Oncology Pivot Gathers Pace

Allianz Races Toward Record Territory as Goldman Sachs Turns Bullish and India Deal Closes

ASML’s €40 Billion Revenue Target Faces a Test as Dividends Flow and Geopolitical Risks Loom

TUI’s Twin Headwinds: A Profit Warning Meets a Fleet Reroute

BASF’s April 30 Crossroads: A Spin-Off Vote, Q1 Earnings, and a Bullish Wall Street Call

Siemens Healthineers Pins Hopes on AI and Spin-Off as Tariffs and China Headwinds Bite

Trending

Almonty Stock
Analysis

Wolfram’s New Calculus: Almonty’s Options Surge Meets a Production Reality Check

by SiterGedge
April 24, 2026
0

The math on Almonty Industries is getting complicated — and that’s exactly why options traders are piling...

Hensoldt Stock

Hensoldt’s Execution Test: Can Record Orders Become Real Revenue?

April 24, 2026
Voestalpine Stock

Voestalpine Forges Ahead on Two Fronts: Rail Megadeals and Chemical-Free Coatings

April 24, 2026
BioNTech Stock

BioNTech’s ADC Breakthrough Fuels Rally as Oncology Pivot Gathers Pace

April 24, 2026
Allianz Stock

Allianz Races Toward Record Territory as Goldman Sachs Turns Bullish and India Deal Closes

April 24, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Wolfram’s New Calculus: Almonty’s Options Surge Meets a Production Reality Check
  • Hensoldt’s Execution Test: Can Record Orders Become Real Revenue?
  • Voestalpine Forges Ahead on Two Fronts: Rail Megadeals and Chemical-Free Coatings

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com